IXCHIQ ® is the world’s first licensed chikungunya vaccine available to address this significant unmet medical need. In addition to Brazil, IXCHIQ ® is approved for the prevention of disease caused by ...

Valneva (VALN) announced that the Brazilian Health Regulatory Agency has granted marketing authorization to its single-dose vaccine Ixchiq for the prevention of disease caused by the chikungunya ...

Valneva SE, a specialty vaccine company, announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose vaccine Ixchiq for the prevention of ...

ACIP maintained its current recommendation for IXCHIQ ® for persons aged ≥18 years traveling to a country or territory where there is a chikungunya outbreak. Additionally, it may be considered ...

This submission follows the recent positive opinion of the European Medicines Agency (EMA) on extension of Ixchiq label to adolescents in the European Union (EU). Ixchiq is the world’s first licensed ...

IXCHIQ ® is the world’s first licensed chikungunya vaccine available to address this significant unmet medical need. In addition to Brazil, IXCHIQ ® is approved for the prevention of disease ...

IXCHIQ® is the world’s first licensed chikungunya ... and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Maintaining independence and ...